Shifa International Hospitals Ltd. Share Transactions by Executives Revealed

Karachi: Recent transactions involving the sale and purchase of shares in Shifa International Hospitals Ltd. by key executives have surfaced, providing insight into the trading activities within the company. The details were disclosed in compliance with the Pakistan Stock Exchange’s regulations regarding transparency in executive transactions.

According to a document released by the hospital group, Mohammad Salim Khan, an Independent Director at Shifa International Hospitals Ltd., executed a series of share sales over the course of four days in May 2025. The transactions began on May 19, 2025, with the sale of 500 shares at a price of 458.00 per share, resulting in a cumulative holding of 112,968 shares, representing 0.18% of the company’s total shares.

Continuing this trend, Mr. Khan sold an additional 500 shares on May 21, 2025, at a rate of 451.00 per share, reducing his cumulative shareholding to 112,468, which remained at 0.18% of the total shares. The following day, on May 22, 2025, he disposed of another 500 shares at 454.00 each, further decreasing his holding to 111,968 shares, maintaining the same percentage of the company’s shareholding.

The final transaction in this series took place on May 23, 2025, when Mr. Khan sold 1,000 shares at a price of 452.10 per share. This brought his cumulative shareholding down to 110,968 shares, still constituting 0.18% of the total shares available.

In a separate transaction, Mr. Rashid Javed, a member of the senior management team, purchased 50 shares of the company on May 22, 2025. These shares were bought at a rate of 459.99 each, bringing his total shareholding to 3,100 shares. Despite this purchase, Mr. Javed’s shares represent a negligible percentage of the company’s total shares.

According to information available from the Pakistan Stock Exchange (PSX), these transactions are part of the mandatory disclosures required to maintain transparency and inform TRE Certificate Holders of significant trading activities by executives and substantial shareholders within listed companies. The market category for these transactions was indicated as “Ready” under the Central Depository Company (CDC) form of share certificates.

These disclosures are crucial for ensuring that all stakeholders are aware of the trading actions of those in positions of influence within the company, thereby helping to maintain market integrity and investor confidence in the listed entity.